Journal of the American Academy of Child & Adolescent Psychiatry
Volume 49, Issue 4 , Pages 356-367, April 2010

Neural Mechanisms of Interference Control and Time Discrimination in Attention-Deficit/Hyperactivity Disorder

  • Timo D. Vloet, M.D.

      Affiliations

    • Cognitive Neurology Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich
    • Aachen University, Germany
    • Corresponding Author InformationCorrespondence to Dr. Timo D. Vloet, Department of Child and Adolescent Psychiatry, Neuenhofer Weg 21, D-52074 Aachen, Germany
  • ,
  • Susanne Gilsbach, M.D.

      Affiliations

    • Cognitive Neurology Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich
    • Aachen University, Germany
  • ,
  • Susanne Neufang, Ph.D.

      Affiliations

    • Cognitive Neurology Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich
    • Aachen University, Germany
  • ,
  • Gereon R. Fink, M.D

      Affiliations

    • Cognitive Neurology Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich
    • University Hospital Cologne
  • ,
  • Beate Herpertz-Dahlmann, M.D.

      Affiliations

    • Aachen University, Germany
  • ,
  • Kerstin Konrad, Ph.D.

      Affiliations

    • Cognitive Neurology Section, Institute of Neuroscience and Medicine (INM-3), Research Centre Juelich
    • Aachen University, Germany

Accepted 22 January 2010. published online 02 March 2010.

Objective

Both executive functions and time perception are typically impaired in subjects with attention-deficit/hyperactivity disorder (ADHD). However, the exact neural mechanisms underlying these deficits remain to be investigated.

Method

Fourteen subjects with ADHD and 14 age- and IQ-matched controls (aged 9 through 15 years) were assessed with functional magnetic resonance imaging while they performed a combined spatial stimulus–response compatibility (SRC) and time duration discrimination (TD) paradigm using identical stimuli for all experimental conditions.

Results

Children with ADHD performed less accurately in the SRC but not in the TD task compared with controls. On the brain level, subjects with ADHD showed significantly reduced neural activity in the left putamen during SRC and reduced fronto-cerebellar activation during TD when compared with the baseline conditions. Compared with subjects with ADHD, control subjects had increased activation in a left-hemispheric fronto-parietal network during the SRC task and in the right superior-frontal gyrus during the TD task. Functional connectivity analyses revealed abnormal fronto-parietal coupling during the SRC task and reduced fronto-cerebellar connectivity during the TD task in the ADHD group compared with controls.

Conclusions

Our findings suggest specific but distinct patterns of cerebral dysfunction associated with interference control and TD processing in ADHD, characterized by both reduced neural activation in regions critical for task performance and reduced co-activation of frontal cortex. Group differences on the behavioral level were controlled by several methodological approaches. Nonetheless, given the use of a block design, we cannot rule out the possibility that between-group differences in behavior confounded the neural activation patterns.

Key Words: ADHD, fMRI, executive functions, time discrimination, functional connectivity

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This study was supported by a grant to K.K. and B.H.-D. by the Deutsche Forschungsgemeinschaft (DFG-KFO112-II, TP5).

 Disclosure: Dr. Herpertz-Dahlmann serves as a consultant for Eli Lilly & Company, and has received research support from AstraZeneca, Eli Lilly & Company, Novartis, and Janssen Cilag. Drs. Vloet, Gilsbach, Neufang, Fink, and Konrad report no biomedical financial interests or potential conflicts of interest.

PII: S0890-8567(10)00078-X

doi:10.1016/j.jaac.2010.01.004

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 49, Issue 4 , Pages 356-367, April 2010